ALKS 3831

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831NCT03201757Alkermes, Inc.Phase 3Completed2023-09-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.